BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37515698)

  • 1. Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records.
    Nakagawa N; Kimura T; Sakate R; Isaka Y; Narita I
    Clin Exp Nephrol; 2023 Nov; 27(11):928-935. PubMed ID: 37515698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records.
    Nakagawa N; Kimura T; Sakate R; Wada T; Furuichi K; Okada H; Isaka Y; Narita I
    Sci Rep; 2023 Sep; 13(1):14771. PubMed ID: 37679492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary membranoproliferative glomerulonephritis on the decline: decreased rate from the 1970s to the 2000s in Japan.
    Kawamura T; Usui J; Kaseda K; Takada K; Ebihara I; Ishizu T; Iitsuka T; Sakai K; Takemura K; Kobayashi M; Koyama A; Kanemoto K; Sumazaki R; Uesugi N; Noguchi M; Nagata M; Suka M; Yamagata K
    Clin Exp Nephrol; 2013 Apr; 17(2):248-54. PubMed ID: 22971963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015.
    Nakagawa N; Hasebe N; Hattori M; Nagata M; Yokoyama H; Sato H; Sugiyama H; Shimizu A; Isaka Y; Maruyama S; Narita I
    Clin Exp Nephrol; 2018 Aug; 22(4):797-807. PubMed ID: 29214407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
    Ruggenenti P; Daina E; Gennarini A; Carrara C; Gamba S; Noris M; Rubis N; Peraro F; Gaspari F; Pasini A; Rigotti A; Lerchner RM; Santoro D; Pisani A; Pasi A; Remuzzi G;
    Am J Kidney Dis; 2019 Aug; 74(2):224-238. PubMed ID: 30929851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A treatment for membranoproliferative glomerulonephritis type II.
    Kiyomasu T; Shibata M; Kurosu H; Shiraishi K; Hashimoto H; Hayashidera T; Akiyama Y; Takeda N
    Nephron; 2002 Jul; 91(3):509-11. PubMed ID: 12119488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry.
    Nakagawa N; Mizuno M; Kato S; Maruyama S; Sato H; Nakaya I; Sugiyama H; Fujimoto S; Miura K; Matsumura C; Gotoh Y; Suzuki H; Kuroki A; Yoshino A; Nakatani S; Hiromura K; Yamamoto R; Yokoyama H; Narita I; Isaka Y
    PLoS One; 2021; 16(9):e0257397. PubMed ID: 34520493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR).
    Urushihara M; Sato H; Shimizu A; Sugiyama H; Yokoyama H; Hataya H; Matsuoka K; Okamoto T; Ogino D; Miura K; Hamada R; Hibino S; Shima Y; Yamamura T; Kitamoto K; Ishihara M; Konomoto T; Hattori M;
    Clin Exp Nephrol; 2021 Sep; 25(9):1018-1026. PubMed ID: 34047871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
    Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
    BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine therapy could be considered for membranoproliferative glomerulonephritis with immunoglobulin A deposits: a case report.
    Hidaka Y; Tamura H; Furuie K; Kuraoka S; Nagata H; Nakazato H
    BMC Nephrol; 2022 Nov; 23(1):358. PubMed ID: 36344919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
    J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Survival.
    de Paula LC; Mazzali M; de Sousa MV
    Ann Transplant; 2023 Jul; 28():e940502. PubMed ID: 37461201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of nephrotic syndrome mimicking membranoproliferative glomerulonephritis (MPGN) and associated with reactive hemophagocytic syndrome after renal death].
    Wakabayashi Y; Tsuchida H; Hamaguchi K; Kaito K; Nakano H; Suzuki S; Miura Y; Watanabe S; Kobayashi M; Kawaguchi Y
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):253-7. PubMed ID: 7602813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
    Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rarity of minimal change disease in Nigerian patients with the nephrotic syndrome.
    Kadiri S; Osobamiro O; Ogunniyi J
    Afr J Med Med Sci; 1993 Dec; 22(4):29-34. PubMed ID: 7839926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between treatment and prognosis of childhood membranoproliferative glomerulonephritis.
    Çaltik Yilmaz A; Aydog Ö; Akyüz SG; Bülbül M; Demircin G; Öner A
    Ren Fail; 2014 Sep; 36(8):1221-5. PubMed ID: 25065413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crescentic glomerulonephritis developing in the course of idiopathic membranoproliferative glomerulonephritis.
    Sharma A; Gupta R; Lal C; Agarwal SK; Dinda AK
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):333-7. PubMed ID: 23538361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan.
    Yamabe H; Johnson RJ; Gretch DR; Fukushi K; Osawa H; Miyata M; Inuma H; Sasaki T; Kaizuka M; Tamura N
    J Am Soc Nephrol; 1995 Aug; 6(2):220-3. PubMed ID: 7579088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.